MIDA-话题@MedSci - 梅斯（MedSci）

#MIDA#

5篇内容 | 971人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1951957, encodeId=00dd195195eff, content=<a href='/topic/show?id=ebc011e60fb' target=_blank style='color:#2F92EE;'>#MIDA#</a>, objectTitle=Midatech收到FDA对MTD201临床计划的反馈, objectType=article, longId=159212, objectId=806b1592125e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=806b1592125e, replyNumber=0, likeNumber=88, createdTime=2019-10-13, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=806b1592125e, moduleTitle=Midatech收到FDA对MTD201临床计划的反馈, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=806b1592125e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1951958, encodeId=2b091951958c7, content=<a href='/topic/show?id=ebc011e60fb' target=_blank style='color:#2F92EE;'>#MIDA#</a>, objectTitle=Midatech宣布其MidaCore金纳米粒子糖尿病疫苗的首项人体研究安全性结果, objectType=article, longId=175958, objectId=e9801e59581e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9801e59581e, replyNumber=0, likeNumber=66, createdTime=2019-09-16, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9801e59581e, moduleTitle=Midatech宣布其MidaCore金纳米粒子糖尿病疫苗的首项人体研究安全性结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e9801e59581e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1951956, encodeId=0a9f195195614, content=<a href='/topic/show?id=ebc011e60fb' target=_blank style='color:#2F92EE;'>#MIDA#</a>, objectTitle=Eur Heart J：MIDA死亡风险评分：退行性二尖瓣返流早晚期死亡预后模型的建立和外部验证, objectType=article, longId=109282, objectId=910810928292, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=910810928292, replyNumber=0, likeNumber=68, createdTime=2017-10-27, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=910810928292, moduleTitle=Eur Heart J：MIDA死亡风险评分：退行性二尖瓣返流早晚期死亡预后模型的建立和外部验证, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=910810928292)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1951955, encodeId=eeac1951955f5, content=<a href='/topic/show?id=ebc011e60fb' target=_blank style='color:#2F92EE;'>#MIDA#</a>, objectTitle=ELCC 2014：非小细胞肺癌患者队列中PD-L1和PD-意大利 Livorno市Toscano肿瘤研究中心肿瘤内科的Armida D’Incec1的表达研究, objectType=article, longId=33185, objectId=63bb33185c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63bb33185c5, replyNumber=0, likeNumber=64, createdTime=2015-02-16, rootId=0, userName=mjldent, userId=5662228, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63bb33185c5, moduleTitle=ELCC 2014：非小细胞肺癌患者队列中PD-L1和PD-意大利 Livorno市Toscano肿瘤研究中心肿瘤内科的Armida D’Incec1的表达研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=63bb33185c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1951954, encodeId=53cc195195477, content=<a href='/topic/show?id=ebc011e60fb' target=_blank style='color:#2F92EE;'>#MIDA#</a>, objectTitle=Midatech募资1600万美元研发口服胰岛素, objectType=article, longId=26349, objectId=d2292634957, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2292634957, replyNumber=0, likeNumber=62, createdTime=2014-06-17, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2292634957, moduleTitle=Midatech募资1600万美元研发口服胰岛素, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d2292634957)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MIDA

2020-05-29

mjldent (审核中...)

前往app查看评论内容

#MIDA#

Midatech收到FDA对MTD201临床计划的反馈

2019-10-13

mjldent (审核中...)

前往app查看评论内容

#MIDA#

Midatech宣布其MidaCore金纳米粒子糖尿病疫苗的首项人体研究安全性结果

2019-09-16

mjldent (审核中...)

前往app查看评论内容

#MIDA#

Eur Heart J：MIDA死亡风险评分：退行性二尖瓣返流早晚期死亡预后模型的建立和外部验证

2017-10-27

mjldent (审核中...)

前往app查看评论内容

#MIDA#

ELCC 2014：非小细胞肺癌患者队列中PD-L1和PD-意大利 Livorno市Toscano肿瘤研究中心肿瘤内科的Armida D’Incec1的表达研究

2015-02-16

仁医06 (审核中...)

前往app查看评论内容

#MIDA#

Midatech募资1600万美元研发口服胰岛素

2014-06-17

科室
- - 订阅+
  - 更多科室
工具
服务